Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 71

2.

Paroxetine : a review of its pharmacology and therapeutic potential in the management of panic disorder.

Foster RH, Goa KL.

CNS Drugs. 1997 Aug;8(2):163-88. doi: 10.2165/00023210-199708020-00010.

PMID:
23338224
3.
4.

Fluvoxamine. An updated review of its pharmacology, and therapeutic use in depressive illness.

Wilde MI, Plosker GL, Benfield P.

Drugs. 1993 Nov;46(5):895-924. Review.

PMID:
7507038
5.
6.

Mirtazapine : A Review of its Pharmacology and Therapeutic Potential in the Management of Major Depression.

Davis R, Wilde MI.

CNS Drugs. 1996 May;5(5):389-402. doi: 10.2165/00023210-199605050-00007.

PMID:
26071050
7.
8.

Tianeptine: a review of its use in depressive disorders.

Wagstaff AJ, Ormrod D, Spencer CM.

CNS Drugs. 2001;15(3):231-59. Review.

PMID:
11463130
9.

Citalopram in the treatment of depression.

Parker NG, Brown CS.

Ann Pharmacother. 2000 Jun;34(6):761-71. Review.

PMID:
10860138
11.

[Mechanisms of action of antidepressants: new data from Escitalopram].

Fabre V, Hamon M.

Encephale. 2003 May-Jun;29(3 Pt 1):259-65. French.

PMID:
12876551
13.
15.
16.

Selective serotonin reuptake inhibitors (SSRIs) and serotonin-norepinephrine reuptake inhibitors (SNRIs) for the prevention of tension-type headache in adults.

Banzi R, Cusi C, Randazzo C, Sterzi R, Tedesco D, Moja L.

Cochrane Database Syst Rev. 2015 May 1;(5):CD011681. doi: 10.1002/14651858.CD011681. Review.

PMID:
25931277
18.

Overview of the safety of citalopram.

Nemeroff CB.

Psychopharmacol Bull. 2003 Winter;37(1):96-121. Review.

PMID:
14561952
19.
20.

Pharmacokinetic-pharmacodynamic relationship of the selective serotonin reuptake inhibitors.

Baumann P.

Clin Pharmacokinet. 1996 Dec;31(6):444-69. Review.

PMID:
8968657

Supplemental Content

Support Center